The Non-Malignant Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCAT 2024 | Strategies for mitigating the negative impact SCD has on growth and development
Maddalena Casale, MD, University of Campania Studies “Luigi Vanvitelli,” Naples, Italy, discusses the impact of sickle cell disease (SCD) on the growth and development of pediatric patients, outlining the interventions that should be implemented to mitigate the adverse effects the disease and to help children realize their full growth potential. This interview took place at the 19th Annual Scientific Conference of the Academy for Sickle Cell and Thalassaemia (ASCAT 2024) in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
